Company: BNBX
Filing Date: 2025-01-17
Form Type: 424B3
Source: 0001104659-25-004510
Chunk: 1

Company: BNB PLUS CORP.
Filing Date: 2025-01-17
Form: 424B3
Chunk 1
---
 will expire on the five-year anniversary
of the Stockholder Approval Date. Each Series D Warrant has an exercise price of $0.32 per share of Common Stock, will become exercisable
upon the Stockholder Approval Date, and will expire on the 18-month anniversary of the Stockholder Approval Date. Each Placement Agent
warrant has an exercise price of $0.32, will become exercisable upon the Stockholder Approval date and will expire on October 30,
2029. We have agreed to hold a special meeting of stockholders on January 23, 2025 to obtain Warrant Stockholder Approval (the “Special
Meeting”).

The closing of the issuance and sale of the Private
Placement Warrants, Common Stock and Pre-Funded Warrants was consummated on October 31, 2024.

The Selling Stockholders of the securities and
any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby
on the principal trading market or any other stock exchange, market or trading facility on which the securities are traded or in private
transactions. These sales may be at fixed or negotiated prices. See “Plan of Distribution” in this prospectus for more information.
We will not receive any proceeds from the resale or other disposition of the Common Stock by the Selling Stockholders. However, we will
receive the proceeds of any cash exercise of the Private Placement Warrants. See “Use of Proceeds” beginning on page 13
and “Plan of Distribution” beginning on page 17 of this prospectus for more information.

Our Common Stock is listed on Nasdaq under
the symbol “APDN.” On January 15, 2025, the last reported sale price of our Common Stock was $0.20 per share.

We are a “smaller reporting company,”
as defined under the federal securities laws and, as such, have elected to comply with certain reduced reporting requirements for this
prospectus and may elect to do so in future filings. See the section titled “Implications of Being a Smaller Reporting Company.”

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 8 of this prospectus and under similar headings in the other documents that are incorporated by reference into this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

Neither the Securities and Exchange Commission (“SEC”) nor any state securities commission has